{"FP": [{"generated": ["cancer patients"], "gold": [], "text": "As known, cancer patients are likely to experience drug interactions due to the increased number and types of chemotherapeutic drugs, their combinations in oncology practice and their narrow therapeutic index, the achievement of a prolonged life expectancy, and the common use of a broad range of ancillary medications to prevent and/or treat cancer-related syndromes and treatment-induced toxicity [8]."}, {"generated": ["early morning"], "gold": [], "text": "The clinical pharmacist recommended dose increases of carbidopa-levodopa to help control his tremors still present early in the morning (Figure 1)."}, {"generated": ["numerous factors"], "gold": [], "text": "Numerous factors can explain discrepancies between study results such as pain models, healthy subjects vs. patients, routes of administration (inhalation vs. oral), and sources of the product [19,20,21]."}, {"generated": ["past two decades"], "gold": [], "text": "During the past two decades, the world has witnessed an increased rate of conventional medicines integrated with CAM for treatment."}, {"generated": ["93.4%"], "gold": [], "text": "In China, 93.4% of cancer patients reported having used CAM in 2009-2010 [4]."}, {"generated": ["South Korean population"], "gold": [], "text": "In South Korean population reported a range from 29% to 83% [5]."}, {"generated": ["to date"], "gold": [], "text": "To date an increasing number of studies in evaluating HDIs have been reported [11]."}, {"generated": ["last decade"], "gold": [], "text": "With the boom in conventional therapeutic drugs, the utilization of herbal remedies sometimes in combination with other medications has increased tremendously over the last decade [1,2]."}, {"generated": ["chronic"], "gold": [], "text": "The TDI effects of these herbals is felt when patients chronically use them because sufficient intermediary metabolites may be generated and this can be deleterious to consumers concomitantly taking conventional medications, as stated earlier."}, {"generated": ["44"], "gold": [], "text": "[44]."}, {"generated": ["29 putative"], "gold": [], "text": "Currently, there are 29 putative SLC22 family members, 18 of which are believed to be OATs."}, {"generated": ["unique substrates"], "gold": [], "text": "Further, unique substrates that interact with Oat1, but not with Oat3 (and vice-versa) have been identified [7]."}, {"generated": ["age \u2265 18 years"], "gold": [], "text": "Keywords: pharmacokinetics, pharmacodynamics, gliclazide, St John's wort, CYP2C9, genotype Go to: Introduction  The incidence of type 2 diabetes is increasing in the community."}, {"generated": ["31%"], "gold": [], "text": "Furthermore, 31% of diabetic patients have been reported to take alternative medicines, most in conjunction with conventional medicines (Ryan et al., 2001)."}, {"generated": ["96 hours"], "gold": [], "text": "Four of these metabolites (6\u03b1, 6\u03b2, 7\u03b1 and 7\u03b2 positions) have been identified in urine, which represented 1, 20, 6 and 14% of urinary recovered dose 96\u2009h after dose, respectively (Oida et al., 1985)."}, {"generated": ["50 \u03bcl"], "gold": [], "text": "Briefly, PCR was performed in a final reaction volume of 50\u2009\u03bcl, which included 20\u2009\u03bcl 2.5 \u00d7 HotMasterMix (Eppendorf, Westbury, NY, USA), approximately 250\u2009ng of human genomic DNA and the primer pairs (0.25\u2009\u03bcM)."}, {"generated": ["carriers of the CYP2C9*3 allele"], "gold": [], "text": "By contrast, for carriers of the CYP2C9*3 allele, the CL/Fs of glipizide (Kidd et al., 1999) and tolbutamide (Kirchheiner et al., 2002a) were significantly different from wild-type subjects, with ratios of 0.18 and 0.58, respectively."}, {"generated": ["initially asymptomatic"], "gold": [], "text": "Although she was initially asymptomatic, she developed right upper quadrant abdominal pain, fatigue, and lower extremity edema by the time of her presentation."}, {"generated": ["immune mechanism"], "gold": [], "text": "The immune mechanism is precipitated by a drug or a metabolite acting as a hapten covalently binding to host cellular protein, converting into an immunogen [24] and thereby eliciting an autoimmune response."}, {"generated": ["50", "100"], "gold": [], "text": "Thereafter, 50\u2009\u03bcL of the IS solution (puerarin, 20\u2009ng/mL in methanol) and 50\u2009\u03bcL of 2% formic acid were added to 100\u2009\u03bcL of the rat tissue homogenate."}, {"generated": ["50", "100"], "gold": [], "text": "Thereafter, 50\u2009\u03bcL of the IS solution (puerarin, 20\u2009ng/mL in methanol) and 50\u2009\u03bcL of 2% formic acid were added to 100\u2009\u03bcL of the rat tissue homogenate."}, {"generated": ["42"], "gold": [], "text": "Group one was administered 42\u2009mg\u00b7kg Data are presented as mean\u2009\u00b1\u2009standard deviation (SD)."}, {"generated": ["LVFX"], "gold": [], "text": "Polygonum capitatum may inhibit the entrance of LVFX into blood, thereby directly affecting its distribution rate in the tissue."}, {"generated": ["2017"], "gold": [], "text": "KY[2017]073)."}, {"generated": ["age"], "gold": [], "text": "Radio labeled digoxin [ Parental and transfected MDCK-II cells were grown in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 1%  The assay for reversible inhibition was conducted in a total volume of 200 \u03bcL in 96-well microplates."}, {"generated": ["30 min"], "gold": [], "text": "GRT and FRE inhibited the reaction rate of CYP2C8, CYP2C9, and CYP3A4 as measured over 30 min (Figure 2a\u2013c)."}, {"generated": ["12.78%"], "gold": [], "text": "GRT containing higher levels of polyphenols, in particular ASP (12.78% compared to 0.36%), demonstrated a more potent inhibition of CYP3A4 activity than FRE with IC CYP2C9 plays a role in the oxidation of xenobiotic and endogenous compounds and is responsible for the metabolism of 15%\u201320% of drugs undergoing phase I metabolism [52,53]."}, {"generated": ["10 mg/mL"], "gold": [], "text": "Stock solutions (10 mg/mL) were prepared by diluting the extracts and compounds in distilled water."}, {"generated": ["age \u2265 18 years"], "gold": [], "text": "Statistical analysis  For each patient, the values of AUC0\u2013\u221e, t1/2 and Cmax of docetaxel in cycle 1 (before E. purpurea) were compared with values obtained in cycle 2 (after E. purpurea)."}, {"generated": ["E. purpurea"], "gold": [], "text": "For example, alkylamide content is known to vary considerably across different parts of E. purpurea plants [20], and DTAI are more abundant in roots than in leaves."}, {"generated": ["advanced cancer"], "gold": [], "text": "Considering the risk of tumour progression, randomization was not in the interest of patients with advanced cancer."}, {"generated": ["Day 1", "Day 15"], "gold": [], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["Day 1", "Day 15"], "gold": [], "text": "Compared to the single administration of digoxin (Day 1), the concomitant administration of digoxin and GTC was associated with a significant reduction in systemic exposure of digoxin (Day 15): AUC The concentration\u2013time profiles of EC, EGC, ECG, and EGCG and the pharmacokinetics parameters are presented in Figure 4 and Table 3."}, {"generated": ["Day 1"], "gold": [], "text": "To identify the effect of ABCB1 genotype on the pharmacokinetic alteration of digoxin by GTC, we compared the percentage changes from Day 1 (digoxin alone treatment) of AUC This study investigated the effect of GTC on the pharmacokinetics of digoxin."}, {"generated": ["age \u2265 18 years"], "gold": [], "text": "Relationship between the catechin AUC Abbreviations: AUC Subject baseline characteristics at the start of the study Note: Data are presented as mean \u00b1 SD for continuous variables and as ratios for categorical variables."}, {"generated": ["1 or 2 weeks"], "gold": [], "text": "After RGE was orally administered to rats at single or multiple doses for 1 or 2 weeks, the plasma concentrations of ginsenosides were also monitored."}, {"generated": ["unknown"], "gold": [], "text": "However, it is unknown whether there is an interaction between AC and DST."}, {"generated": ["neonates"], "gold": [], "text": "Endogenous digoxin substances are present in neonates and patients with renal dysfunction, and these substances may lead to elevated or false-positive digoxin plasma concentration monitoring results."}, {"generated": ["in vitro", "in vivo"], "gold": [], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": ["in vitro", "in vivo"], "gold": [], "text": "In vivo, digoxin was administered intravenously to control rats and citronellal pretreated experimental rats, and in vitro, the transcellular transport of   Single TCM: Single TCM formulations that are capable of inhibiting or downregulating P-gP include Conioselinum anthriscoides \u201cChuanxiong\u201d (Chuanxiong), Vernonia amygdalina (Biantaobanjiuju), Tapinanthus sessilifolius, Carica papaya (Mugua) and Ginkgo biloba L. (Yinxing)."}, {"generated": ["above 18 years"], "gold": [], "text": "2 above (substituting logEC50 for logIC50)."}, {"generated": ["S.D.", "Mean"], "gold": [], "text": "Mean\tS.D."}, {"generated": ["S.D.", "Mean"], "gold": [], "text": "Mean\tS.D."}, {"generated": ["S.D.", "Mean"], "gold": [], "text": "Mean\tS.D."}, {"generated": ["S.D.", "Mean"], "gold": [], "text": "Mean\tS.D."}, {"generated": ["mean"], "gold": [], "text": "Data shown are the means \u00b1 S.D."}, {"generated": ["triple"], "gold": [], "text": "of triplicate determinations."}, {"generated": ["human liver microsomes", "human P450 forms"], "gold": [], "text": "Purified centelloids are weak inhibitors in human liver microsomes and human P450 forms expressed by E. coli of CYP2C19, CYP3A4, CYP2D6, and CYP2C9."}, {"generated": ["human liver microsomes", "human P450 forms"], "gold": [], "text": "Purified centelloids are weak inhibitors in human liver microsomes and human P450 forms expressed by E. coli of CYP2C19, CYP3A4, CYP2D6, and CYP2C9."}, {"generated": ["150 \u03bcL"], "gold": [], "text": "Then, 150 \u03bcL acetonitrile containing 1 ng/mL berberine (IS) was added to the reconstituted standard curves."}, {"generated": ["24 h"], "gold": [], "text": "Post-preparative stability was evaluated by comparing the extracted QC samples maintained in the autosampler at 6 \u00b0C for 24 h (compared with the untreated QC samples)."}, {"generated": ["rat"], "gold": [], "text": "Each rat in the combination group received a mixture of fimasartan (3 mg/kg), amlodipine (5 mg/kg), and hydrochlorothiazide (5 mg/kg) dissolved in saline containing 10% DMSO."}, {"generated": ["50"], "gold": [], "text": "For amlodipine analysis, 50 \u03bcL aliquots were mixed with 150 \u03bcL acetonitrile containing 1 ng/mL berberine (IS)."}, {"generated": ["M.P."], "gold": [], "text": "and M.P."}, {"generated": ["chronic"], "gold": [], "text": "However, there are several challenges associated with the chronic nature of HAART administration."}, {"generated": ["72 h"], "gold": [], "text": "The material was allowed to extract for 72 h at room temperature during which supernatant was decanted every 24 h and the solid residue reconstituted in the same volume of purified water for the extraction process to be repeated."}, {"generated": ["1000 mg once daily", "1000 mg \u00d7 4 times daily"], "gold": [], "text": "Therefore, two simulation scenarios were used to evaluate the magnitude of any interaction, (AAP 1000 mg once daily + GGT 7680 mg once daily) and (AAP 1000 mg \u00d7 4 times daily + GGT 7680 mg once daily) in a week."}, {"generated": ["1000 mg once daily", "1000 mg \u00d7 4 times daily"], "gold": [], "text": "Therefore, two simulation scenarios were used to evaluate the magnitude of any interaction, (AAP 1000 mg once daily + GGT 7680 mg once daily) and (AAP 1000 mg \u00d7 4 times daily + GGT 7680 mg once daily) in a week."}, {"generated": ["elderly"], "gold": [], "text": "Single time-point, phenotypic metabolic ratios were used to determine whether long-term supplementation of St. John\u2019s wort, garlic oil, Panax ginseng, and Ginkgo biloba affected CYP1A2, CYP2D6, CYP2E1, or CYP3A4 activity in elderly subjects."}, {"generated": ["greater than 65 years"], "gold": ["greater than 65 years of age"], "text": "[1\u20133,8,9] Still other surveys indicate that herbal supplement usage is prevalent among patients taking prescription medications,[10\u201312] with many individuals greater than 65 years of age."}, {"generated": ["age-related changes"], "gold": [], "text": "Moreover, age-related changes have been observed in the pharmacokinetics of several CYP substrates,[28\u201330] as well as certain CYP enzymes,[29,30] thus the question remains as to whether such effects may extend to botanical supplements and their effect on drug metabolism in the elderly."}, {"generated": ["five days"], "gold": [], "text": "Adherence to these restrictions was further emphasized five days before each probe drug administration."}, {"generated": ["45"], "gold": [], "text": "[45] Go to: RESULTS General Experimental Observations  All subjects completed the study and no serious adverse events occurred during the course of the investigation."}, {"generated": ["age \u2265 18 years"], "gold": [], "text": "Table I  Pre- and Postsupplementation Phenotypic Ratios (means, 95% confidence intervals) Phenotypic Ratio (CYP)\tSupplement\tPresupplementation (mean and 95% CI)\tPostsupplementation."}, {"generated": ["17"], "gold": [], "text": "[17] The single-time point phenotypic ratio approach confirmed what other investigators observed with St. John\u2019s wort when more conventional \u201carea-under-the-curve\u201d methods were utilized to determine midazolam clearance."}, {"generated": ["54"], "gold": [], "text": "[54] Thus, a potential interaction may exist between these agents and St. John\u2019s wort."}, {"generated": ["42"], "gold": [], "text": "[42] The difference in extent of inhibition between the two age groups hints at either an age-related diminution in CYP2E1 responsivity or a dissimilarity in allyl sulfide content between the garlic supplements."}, {"generated": ["elderly"], "gold": [], "text": "[11,12] Such an interaction is particularly relevant to elderly patients on anticoagulant therapy."}, {"generated": ["18"], "gold": [], "text": "[18] Taken together these findings indicate that herb-drug interactions attributable to G. biloba are not the result of phytochemical-mediated effects on CYP isoforms."}, {"generated": ["62"], "gold": [], "text": "[62] CYP2C9 is the principal isoform involved in the biotransformation of warfarin (more particularly the active enantiomer, S-warfarin) and the aforementioned reports hint strongly at a ginseng-mediated induction of this enzyme."}, {"generated": ["6-11"], "gold": [], "text": "[4] Studies on phytochemical analysis of G. kola seeds [6\u201311] reveal benxophenones, xanthones, alkaloids, phenols, tannins and saponins, kolaviron a biflavonoid complex, and metallic ions such as aluminum, magnesium, calcium and copper as major chemical components of G. kola."}, {"generated": ["38"], "gold": [], "text": "[38]  Although, the exact mechanism responsible for the delayed and decreased absorption of quinine in the presence of G. kola in this current study is not known, it is possible that quinine may have interacted through complex formation with the trace metals or flavonoids usually found in G. kola [6, 11] as evidenced from a significant reduction in the Cmax and tmax of quinine but no significant change in parameters which are indicative of interference with elimination."}, {"generated": ["77"], "gold": [], "text": "In Stage 2 77 additional participants were randomized to either 1,200 mg S. frutescens or placebo."}, {"generated": ["adults"], "gold": [], "text": "More than 50% of adults in KwaZulu-Natal attending public sector facilities for ART initiation disclose using TCAM [10], and similar levels of TCAM use by HIV positive individuals may occur worldwide [11]."}, {"generated": ["global public health problem"], "gold": [], "text": "Chronic kidney disease (CKD) is a global public health problem with an increasing incidence and a lot of economic burden for treatment."}, {"generated": ["age"], "gold": [], "text": "After obtaining institutional ethics committee approval (project number and ethics code: 294155) from the university research affairs, patients' demographic information (sex, age, educational status, occupational status, and marital status) were collected from patients' hospital records or by direct interviewing of patients and filled in a specially designed form for this study."}, {"generated": ["20-60 years"], "gold": ["20\u201360 years"], "text": "Regarding CAM nonusers, the majority were in the age group of 20\u201360 years with the male/female ratio of 73/27 percent."}, {"generated": ["50-70 years"], "gold": ["50\u201370 years"], "text": "The majority of the patients identified as herbal users were in the age range of 50\u201370 years, and herbal usage prevalence was high among this age range."}, {"generated": ["50-64"], "gold": ["50\u201364"], "text": "'s study,[25] which reported that the trend was more prevalent among middle-aged (50\u201364) patients compared to other age groups."}, {"generated": ["27"], "gold": [], "text": "[27] In the study performed by Roozbeh et al."}, {"generated": ["18-year-old"], "gold": [], "text": "Unfortunately, a [18 F]-fluorethylenthyrosin positron emission tomography positive residual tumor was detected 2 months after the end of radiotherapy."}, {"generated": ["whole blood"], "gold": [], "text": "Briefly, whole blood (0.5\u2009mL) was diluted twofold with freshly prepared normal saline and incubated at 37\u2009\u00b0C for at least 6\u2009min."}, {"generated": ["age \u2265 18 years"], "gold": [], "text": "Table 2  Pharmacokinetic parameters of S-warfarin and R-warfarin  \tMean (95% CI)\tGeometric mean ratio (90% CI)  \tWarfarin only\tWarfarin and cranberry\tWarfarin and garlic\tWarfarin and cranberry/warfarin only\tWarfarin and garlic/warfarin only S-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.3 (1.1\u20131.6)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20131.9)\t1.7 (1.5\u20132.0)\t1.9 (1.5\u20132.2)\t0.94 (0.67\u20131.29)\t1.06 (0.77\u20131.47) \u2003t1/2 (h)\t38.6 (35.7\u201341.5)\t34.9 (31.0\u201338.8)\t41.2 (35.1\u201347.3)\t0.94 (0.79\u20131.12)\t0.99 (0.83\u20131.18) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t60.3 (54.5\u201366.1)\t63.0 (57.3\u201368.8)\t65.5 (55.3\u201375.6)\t1.04 (0.94\u20131.67)\t1.06 (0.95\u20131.19) \u2003CL/F (mL\u2009h\u22121)\t213 (193\u2013232)\t204 (183\u2013224)\t202 (175\u2013229)\t0.89 (0.80\u20130.99)\t1.05 (0.94\u20131.17) \u2003Fraction unbound (fu)\t0.010 (0.007\u20130.013)\t0.010 (0.007\u20130.014)\t0.011 (0.008\u20130.014)\t1.00 (0.75\u20131.25)\t1.12 (0.39\u20131.84)  \t \t \t \t \t  R-warfarin \u2003tmax (h)\t1.4 (1.1\u20131.6)\t1.9 (1.1\u20132.7)\t1.8 (0.7\u20132.9)\tNA\tNA \u2003Cmax (\u03bcg\u2009mL\u22121)\t1.8 (1.7\u20132.0)\t1.7 (1.5\u20131.9)\t1.9 (1.5\u20132.2)\t0.90 (0.67\u20131.21)\t1.02 (0.8\u20131.4) \u2003t1/2 (h)\t55.6 (46.2\u201365.0)\t47.7 (41.5\u201353.9)\t52.6 (47.4\u201357.9)\t0.93 (0.80\u20131.08)\t0.98 (0.84\u20131.14) \u2003AUC (\u03bcg\u2009mL\u22121\u2009h)\t108.7 (90.0\u2013127.3)\t105.8 (91.7\u2013119.9)\t105.0 (96.3\u2013113.7)\t1.0 (0.9\u20131.1)\t0.99 (0.87\u20131.13) \u2003CL/F (mL\u2009h\u22121)\t123 (106\u2013140)\t124 (109\u2013139)\t121 (112\u2013131)\t0.87 (0.75\u20130.99)\t0.96 (0.84\u20131.11) \u2003Fraction unbound (fu)\t0.006 (0.004\u20130.007)\t0.005 (0.004\u20130.007)\t0.006 (0.004\u20130.007)\t0.95 (0.72\u20131.18)\t1.04 (0.80\u20131.29) Open in a separate window Abbreviations: AUC, area under the plasma concentration\u2013time curve; CI, confidence interval; CL, clearance; CL/F, apparent clearance; Cmax, maximum concentration; F, bioavailability; NA, not applicable; tmax, time to Cmax."}, {"generated": ["2006b"], "gold": [], "text": "(2006b) included 7 patients with atrial fibrillation, whereas Ansell et al."}, {"generated": ["2007"], "gold": [], "text": "(2007) concluded that there were no pharmacodynamic interactions between warfarin and cranberry juice, but they employed a low dose of warfarin (10\u2009mg), which made this end point difficult to assess."}, {"generated": ["recent"], "gold": [], "text": "Academic Editor: Igho J. Onakpoya In recent popular publications as well as in widely used information websites directed to cancer patients, valerian is claimed to have a potential of adverse interactions with anticancer drugs."}, {"generated": ["elderly"], "gold": [], "text": "It therefore was recommended that they should be avoided in the elderly [10, 12]."}, {"generated": ["36"], "gold": [], "text": "[36]."}, {"generated": ["daily"], "gold": [], "text": "Daily before going to bed, participants took two tablets, with 500\u2009mg valerian extract each (extraction solvent ethanol 70%, valerenic acid content 5.51\u2009mg/tablet), for 14 subsequent days."}, {"generated": ["12 weeks"], "gold": [], "text": "Haloperidol (38\u2009mg/kg bw) was applied intramuscularly once every 4 weeks over 12 weeks beginning after 15 days of treatment with valerian [51]."}, {"generated": ["no specific age mentioned"], "gold": [], "text": "In summary, it can be concluded that warnings regarding a specific risk of interactions of valerian are without any recent evidence."}, {"generated": ["hours to months"], "gold": [], "text": "Although DIP can occur from hours to months after the beginning of treatment, Another typical feature of DIP is its reversibility after drug discontinuation."}, {"generated": ["n\u00e3o encontrado"], "gold": [], "text": "Uma investiga\u00e7\u00e3o ampla foi realizada, incluindo LBA, estudos de imagem, detec\u00e7\u00e3o de doen\u00e7as autoimunes, cateterismo card\u00edaco direito e bi\u00f3psia mioc\u00e1rdica."}, {"generated": ["adulto", "circunstancial"], "gold": [], "text": "A administra\u00e7\u00e3o circunstancial de inibidores da isoenzima CYP2D6 e a presen\u00e7a de um fen\u00f3tipo de metaboliza\u00e7\u00e3o lenta de CYP2D6 podem ter resultado na acumula\u00e7\u00e3o t\u00f3xica da venlafaxina e na manifesta\u00e7\u00e3o cl\u00ednica subsequente."}, {"generated": ["adulto", "circunstancial"], "gold": [], "text": "A administra\u00e7\u00e3o circunstancial de inibidores da isoenzima CYP2D6 e a presen\u00e7a de um fen\u00f3tipo de metaboliza\u00e7\u00e3o lenta de CYP2D6 podem ter resultado na acumula\u00e7\u00e3o t\u00f3xica da venlafaxina e na manifesta\u00e7\u00e3o cl\u00ednica subsequente."}, {"generated": ["maioria"], "gold": [], "text": "A maioria dos medicamentos card\u00edacos foi, portanto, descontinuada."}, {"generated": ["35-year-old"], "gold": [], "text": "O caso ocorreu em uma paciente previamente h\u00edgida de 35 anos de idade que foi submetida a investiga\u00e7\u00e3o exaustiva ap\u00f3s a exclus\u00e3o de outras poss\u00edveis causas."}, {"generated": ["menopausal"], "gold": [], "text": "This study aims to confirm the safety of red ginseng and herb extract complex (RHC), which are used to relieve menopausal symptoms."}, {"generated": ["age \u2265 18 years"], "gold": [], "text": "Meanwhile, the exclusion criteria were: 1) women who became menopausal from surgery or chemotherapy; 2) women who underwent hysterectomy; 3) women with a history of endometrial hyperplasia or endometrial, breast, or sex hormone\u2013related cancers; 4) women with uncontrolled hypertension (160/100\u00a0mmHg or higher); 5) women with uncontrolled diabetes mellitus (fasting blood sugar 180\u00a0mg/dL or higher, or cases of starting or changing medication due to diabetes within 3\u00a0mo); 6) uncontrolled thyroid patients; 7) women who have had severe migraines within the last year or who have been diagnosed with thromboembolism, cerebrovascular disease, or serious cardiovascular disease; 8) women with atypical uterine bleeding after 1\u00a0yr of menopause; 9) women who have taken sleep inducers, antidepressants, selective estrogen receptor modulators, antihyperlipidemic drugs, antithrombotic drugs (Aspirin, Warfarin, and Clopidogrel), bisphosphonates, or calcitonin within 4\u00a0wk; 10) women who have taken plant hormones (isoflavone, flaxseed, pomegranate, horseradish, white sorghum, red shamrock, and red ginseng products) in the form of supplements or medicines within 4\u00a0wk; 11) women who have continuously taken functional foods and herbal medicines that could affect bone health, blood lipid lipids (triglyceride and cholesterol), and blood circulation within 4\u00a0wk; 12) women who were administered female hormone formulations within 6\u00a0mo; 13) women with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels exceeding 3 times the laboratory's normal upper limit; 14) women with creatinine levels exceeding 2 times the laboratory's normal upper limit; 15) women with a history of drug or alcohol abuse; 16) women who have performed intensive exercises (more than 10\u00a0h) within 3\u00a0mo; 17) women with hypersensitivity to the test drug or its ingredients; 18) women with clinically significant abnormalities based on mammographies or Pap smears (Category 0 or higher than 3 of Breast Imaging Reporting and Data System (BI-RADS)) is confirmed (in the case of BI-RADS Category 0, subject registration is possible after confirming additional test results; in the case of Pap smear, atypical squamous cell of undetermined significance can be registered); 19) women who have participated in other clinical trials within 1\u00a0mo of the start of the current study or who are planning to participate in another clinical trial during the study period; and, 20) in cases where the researchers decided that the subject is unsuitable to participate in this study."}, {"generated": ["large-scale menopausal subjects"], "gold": [], "text": "However, further research is needed on the safety of RHC intake for a long period in large-scale menopausal subjects."}, {"generated": ["120-fold variability", "13-fold variability"], "gold": [], "text": "For example, 120-fold variability of UGT1A6 expression in human liver might result in 13-fold variablity in serotonin glucuronidation [24]."}, {"generated": ["120-fold variability", "13-fold variability"], "gold": [], "text": "For example, 120-fold variability of UGT1A6 expression in human liver might result in 13-fold variablity in serotonin glucuronidation [24]."}, {"generated": ["inhibition kinetic analysis"], "gold": [], "text": "Inhibition kinetic analysis of celastrol (Cela) towards UGT2B7-catalyzed 4-MU glucuronidation."}, {"generated": ["no herb\u2013drug interaction"], "gold": [], "text": "In case of ginseng interactions, it was reported that no herb\u2013drug interaction between single oral dose of Korean red ginseng extract (RGE) (0.5\u20132.0 g/kg) and the probe substrates for five cytochrome P450 (CYP) enzymes (i.e., CYP1A2, 2C9, 2C19, 2D6, 3A) in mouse [12]."}, {"generated": ["1-week"], "gold": [], "text": "Plasma concentration-time profiles of the ginsenosides (A) Rb1, (B) Rb2, (C) Rc, (D) Rd, (E) PPD, and (F) PPT in the rat plasma after 1-week repeated administration of red ginseng extract (RGE)."}, {"generated": ["\u00b11 day"], "gold": [], "text": "For each visit, a deviation of\u00a0\u00b11\u00a0day was permitted."}, {"generated": ["PCOS patients"], "gold": [], "text": "Oxidative stress is dramatically increased in PCOS patients, when oxidant/antioxidant status is measured by circulating serum markers, including catalase (CAT), glutathione peroxidase (GPx), superoxide dismutase (SOD), and malondialdehyde (MDA) [3]."}, {"generated": ["Citrus Sinensis"], "gold": [], "text": "Citrus Sinensis (L.) Osbeck from Rutaceae family mainly contains hesperidin, polymethoxylated flavonoids (PMF), and terpenoids (limonene and linalool), and these phenolic bioactive compounds indicate considerable cytoprotective effects against OS [18]."}, {"generated": ["C. sinensis"], "gold": [], "text": "Moreover, hesperidin in C. sinensis increases the levels of antioxidants including SOD and CAT, and decreases the MDA level [19]."}, {"generated": ["1 mL", "120 g", "4 \u00b0C", "200 \u00b5L", "4 h"], "gold": [], "text": "One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 \u00b5L of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 \u00b0C for further analyses."}, {"generated": ["1 mL", "120 g", "4 \u00b0C", "200 \u00b5L", "4 h"], "gold": [], "text": "One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 \u00b5L of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 \u00b0C for further analyses."}, {"generated": ["1 mL", "120 g", "4 \u00b0C", "200 \u00b5L", "4 h"], "gold": [], "text": "One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 \u00b5L of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 \u00b0C for further analyses."}, {"generated": ["1 mL", "120 g", "4 \u00b0C", "200 \u00b5L", "4 h"], "gold": [], "text": "One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 \u00b5L of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 \u00b0C for further analyses."}, {"generated": ["1 mL", "120 g", "4 \u00b0C", "200 \u00b5L", "4 h"], "gold": [], "text": "One mL of methanolic extract (5 mg/mL in acetone-water solution) was mixed with 200 \u00b5L of Folin-Ciocalteau reagent and 1 mL of 2% Na Total flavonoids were determined using the AlCl The herbal mixture powder (120 g) was exposed to hydrodistillation using a Clevenger type apparatus for about 4 h. Then, the obtained dark yellow oil was dried over anhydrous sodium sulfate, measured, and stored in a dark glass at 4 \u00b0C for further analyses."}, {"generated": ["75 participants"], "gold": [], "text": "Then, 75 participants were randomly allocated into 3 groups including group 1: CC (n = 25); group 2: herbal mixture (n = 25); and group 3: CC with herbal mixture (n = 25)."}, {"generated": ["no significant difference in the FBS level (p = 0.212) in group 2"], "gold": [], "text": "Moreover, the binary comparison indicated no significant difference in the FBS level (p = 0.212) in group 2, the insulin level (p = 0.842) in group 3, and the HOMA-IR level (p = 0.403) in group 3 compared to group 1."}, {"generated": ["day 28", "day 14", "day 0"], "gold": [], "text": "Safety was evaluated by clinical interview and physical examination and by laboratory assessment (blood counts, chemistry, CD4+ T-cell count, and HIV-1 RNA load) on days 0, 14, and 28."}, {"generated": ["day 28", "day 14", "day 0"], "gold": [], "text": "Safety was evaluated by clinical interview and physical examination and by laboratory assessment (blood counts, chemistry, CD4+ T-cell count, and HIV-1 RNA load) on days 0, 14, and 28."}, {"generated": ["day 28", "day 14", "day 0"], "gold": [], "text": "Safety was evaluated by clinical interview and physical examination and by laboratory assessment (blood counts, chemistry, CD4+ T-cell count, and HIV-1 RNA load) on days 0, 14, and 28."}, {"generated": ["median"], "gold": [], "text": "The median CD4+ T-cell count was 498 (range, 244 to 962) cells/mm3."}, {"generated": ["8 days"], "gold": [], "text": "The following treatments were administered for 8\u00a0days each: placebo twice daily (treatment A), EGb 761\u00ae 120\u00a0mg twice daily (treatment B), and EGb 761\u00ae 240\u00a0mg in the morning and placebo in the evening (treatment C)."}, {"generated": ["240-mg"], "gold": [], "text": "A maximum exposure was realized with a 240-mg EGb 761\u00ae daily dose, and exposure duration was sufficient to eventually induce CYPs, as steady state for EGb 761\u00ae components was reached, and 1\u00a0week is typically sufficient to achieve full induction [35]."}, {"generated": ["8-day period"], "gold": [], "text": "does not affect CYP2C19 activity when administered over an 8-day period."}, {"generated": ["45.6"], "gold": [], "text": "Based on the two CONSORT statements, the reporting percentage for each of the articles ranged from 36.5% to 61.5% and the mean percentage for all articles was 45.6%."}, {"generated": ["no history"], "gold": [], "text": "She had no history of warfarin use, but warfarin was detected in her blood serum analysis."}, {"generated": ["unknown"], "gold": [], "text": "Other diagnostic considerations in a patient presenting with coagulopathy of unknown origin include warfarin or super-warfarin exposure, disseminated intravascular coagulation (DIC), vitamin K malabsorption, and pathologic inhibitors of coagulation (6)."}, {"generated": ["well\u2010characterized composition"], "gold": [], "text": "Silibinin was selected as a model herbal product perpetrator based on well\u2010characterized composition, availability of human pharmacokinetic data, and in vitro inhibitory potency (K Because standard approaches to evaluate herb\u2013drug interactions mediated via inhibition of intestinal glucuronidation in humans have not been described, two different modeling platforms were used to predict the likelihood and magnitude of the silibinin\u2013raloxifene interaction."}, {"generated": ["8-hour", "6-hour", "12-hour", "10-hour", "3-hour", "4-hour"], "gold": [], "text": "However, multiple-dose combination of curcumin with gliclazide produced significantly greater reduction in percent blood glucose reduction at 3-, 4-, 6-, 8-, 10-, and 12-hour intervals after treatment in normal rats and rabbits when compared with gliclazide control."}, {"generated": ["8-hour", "6-hour", "12-hour", "10-hour", "3-hour", "4-hour"], "gold": [], "text": "However, multiple-dose combination of curcumin with gliclazide produced significantly greater reduction in percent blood glucose reduction at 3-, 4-, 6-, 8-, 10-, and 12-hour intervals after treatment in normal rats and rabbits when compared with gliclazide control."}, {"generated": ["8-hour", "6-hour", "12-hour", "10-hour", "3-hour", "4-hour"], "gold": [], "text": "However, multiple-dose combination of curcumin with gliclazide produced significantly greater reduction in percent blood glucose reduction at 3-, 4-, 6-, 8-, 10-, and 12-hour intervals after treatment in normal rats and rabbits when compared with gliclazide control."}, {"generated": ["8-hour", "6-hour", "12-hour", "10-hour", "3-hour", "4-hour"], "gold": [], "text": "However, multiple-dose combination of curcumin with gliclazide produced significantly greater reduction in percent blood glucose reduction at 3-, 4-, 6-, 8-, 10-, and 12-hour intervals after treatment in normal rats and rabbits when compared with gliclazide control."}, {"generated": ["8-hour", "6-hour", "12-hour", "10-hour", "3-hour", "4-hour"], "gold": [], "text": "However, multiple-dose combination of curcumin with gliclazide produced significantly greater reduction in percent blood glucose reduction at 3-, 4-, 6-, 8-, 10-, and 12-hour intervals after treatment in normal rats and rabbits when compared with gliclazide control."}, {"generated": ["8-hour", "6-hour", "12-hour", "10-hour", "3-hour", "4-hour"], "gold": [], "text": "However, multiple-dose combination of curcumin with gliclazide produced significantly greater reduction in percent blood glucose reduction at 3-, 4-, 6-, 8-, 10-, and 12-hour intervals after treatment in normal rats and rabbits when compared with gliclazide control."}, {"generated": ["clinical popularity"], "gold": [], "text": "Despite its clinical popularity, CBZ possesses several pharmacokinetic properties which make it prone to interaction with coadministered substances, including drugs, herbal products, and food [7]."}, {"generated": ["2012"], "gold": [], "text": "2012), Cochrane Database of Systematic Reviews (2005\u2013Dec."}, {"generated": ["2012"], "gold": [], "text": "2012)."}, {"generated": ["human"], "gold": [], "text": "Although honey was shown to decrease the oral bioavailability of CBZ in rabbits, it had no effect on the pharmacokinetic parameters of CBZ in human [63\u201365]."}, {"generated": ["rats", "two children"], "gold": [], "text": "As regards the dietary supplement-CBZ interactions, folinic acid did not alter the plasma level of CBZ in rats [61] while nicotinamide increased CBZ plasma level and decreased its clearance in two children with epilepsy [70]."}, {"generated": ["rats", "two children"], "gold": [], "text": "As regards the dietary supplement-CBZ interactions, folinic acid did not alter the plasma level of CBZ in rats [61] while nicotinamide increased CBZ plasma level and decreased its clearance in two children with epilepsy [70]."}, {"generated": ["usually"], "gold": [], "text": "Patients on antiepileptic therapy are usually on a long-term basis."}, {"generated": ["highest number of patients"], "gold": [], "text": "This is possibly because the highest number of patients with type-2 diabetes fell within that age group."}, {"generated": ["thousands of years"], "gold": [], "text": "Herbs have been used for primary health care for thousands of years before the advent of modern medicines."}, {"generated": ["15 min"], "gold": [], "text": "After administration, aspirin is rapidly hydrolyzed in the body with an elimination half-life of approximatly 15 min [11,12]."}, {"generated": ["drug metabolizing enzymes", "drug transporters"], "gold": [], "text": "PXR activating drugs (e.g., rifampicin) or herbal preparations (e.g., St. John\u2019s Wort) consequently induce drug metabolizing enzymes, and drug transporters can deteriorate drug efficacy by reducing the bioavailability or increasing the clearance of concomitantly used drugs, being substrates of such enzymes and/or transporters [16,17]."}, {"generated": ["drug metabolizing enzymes", "drug transporters"], "gold": [], "text": "PXR activating drugs (e.g., rifampicin) or herbal preparations (e.g., St. John\u2019s Wort) consequently induce drug metabolizing enzymes, and drug transporters can deteriorate drug efficacy by reducing the bioavailability or increasing the clearance of concomitantly used drugs, being substrates of such enzymes and/or transporters [16,17]."}, {"generated": ["up to a dilution of 1%"], "gold": [], "text": "Therefore, Samento and Banderol were tested up to a dilution of 1% in the induction assay."}, {"generated": ["four days"], "gold": [], "text": "Effects of Samento (0.033\u20131%) and the positive control rifampicin (20 \u00b5M) on the protein expression of P-glycoprotein (P-gp) after four days of exposure."}, {"generated": ["t = 0"], "gold": [], "text": "Expression of CYP2J2 mRNA was quantified by RT-PCR and results normalized to \u03b22mg and to t = 0."}, {"generated": ["long time"], "gold": [], "text": "It has been officially listed in the Korean Pharmaceutical Codex for a long time and an aqueous suspension has recently been developed for convenient administration [1]."}, {"generated": ["66.77%", "41.06%"], "gold": [], "text": "The APG-pretreated rats showed significant inhibition of the BCPR/ABCG2 protein that is (66.77% and 41.06% inhibition, respectively) as compared to DAS only (p < 0.05)."}, {"generated": ["66.77%", "41.06%"], "gold": [], "text": "The APG-pretreated rats showed significant inhibition of the BCPR/ABCG2 protein that is (66.77% and 41.06% inhibition, respectively) as compared to DAS only (p < 0.05)."}, {"generated": ["one week prior to experiment"], "gold": [], "text": "All animals were retained in polypropylene cages: 6 animals were caged (n = 6) per cage with a 12-h light/dark cycle, at 25 \u00b0C in humane conditions with free access to food and water and adapted to the living conditions one week prior to experiment The animals were categorized into four groups (n = 6) and fasted for 12 h before the experiment."}, {"generated": ["7th day"], "gold": [], "text": "on the 7th day, 2\u2009h after APG 40 mg/kg administration, and Group IV was administered with APG 40 mg/kg for 7 days."}, {"generated": ["in vivo studies"], "gold": [], "text": "Further thorough in vivo studies of the APG\u2013DAS interaction in humans are warranted to support these findings."}, {"generated": ["M.A.A."], "gold": [], "text": "and M.A.A."}, {"generated": ["K.M.A."], "gold": [], "text": "; supervision, K.M.A."}, {"generated": ["rats"], "gold": [], "text": "Hepatic (A) and intestinal (B) BCRP/ABCG2 protein expression in rats after DAS administration with or without APG pretreatment."}, {"generated": ["elderly"], "gold": [], "text": "Concomitant ingestion of botanical supplements with prescription medications, therefore, should be strongly discouraged in the elderly."}, {"generated": ["adult women"], "gold": [], "text": "The purpose of this study was to evaluate the effect of SC extract supplementation on quadriceps muscle strength (QMS) and lactate at rest in adult women."}, {"generated": ["first hypothesis"], "gold": [], "text": "Our first hypothesis is that the supplementation of SC extract in humans can increase muscle strength."}, {"generated": ["5"], "gold": [], "text": "In the main test session, subjects performed 5 isokinetic knee extensions of the leg at an angular velocity of 60 degrees/second, and subjects recovered passively for 2 min between sets of measurements [26,27]."}, {"generated": ["mean"], "gold": [], "text": "The mean SC extract supplementation and placebo compliance were 97.3% (90.2\u2212100%) in the SC group and 95.8% (86.7\u2013100%) in the placebo group."}, {"generated": ["baseline", "12 weeks"], "gold": [], "text": "Resting lactate level was measured at baseline and after 12 weeks, and results are presented in Figure 2."}, {"generated": ["baseline", "12 weeks"], "gold": [], "text": "Resting lactate level was measured at baseline and after 12 weeks, and results are presented in Figure 2."}, {"generated": ["several investigators"], "gold": [], "text": "The tail suspension test, which also measures changes in immobility in rodents after antidepressant treatment, was applied by several investigators (Butterweck, Christoffel, et al., 2003; Machado et al., 2008; Tian et al., 2014) and SJW extracts significantly reduced the time of immobility in this test."}, {"generated": ["control group"], "gold": [], "text": "If the control group also received medicinal mushrooms, there should be significant dosage differences of the mushrooms in the treatment group."}, {"generated": ["age \u2265 18 years"], "gold": [], "text": "Reduce T cell apoptosis and caspase 3 activity through downregulating Bax expression in T cells [170] Increase in efficacy and survival [20], better symptomatic relief [20] increase in T cells count (CD4, CD4/CD8) [20] Better symptomatic relief [141] and increase appetite [144] Less reduction in WBC (CD3+, CD4+ T cells, NK cells) [141, 144], platelets [144] Pharmacodynamic interactions between medicinal mushrooms and cytotoxic drugs in preclinical studies Increase in tumor inhibition effect [83, 84, 98] and survival time [63] Less decrease in WBC [83, 84, 145], platelets [83] and other bone marrow cells [84] Greater recovery rate from intestinal damage caused by 5-FU [173] Increase in survival [67], cytotoxicity and inhibit metastasis [111] Reduce immunosuppression (reduce the decrease in phagocytic activity, antibody production [111], delayed hypersensitivity [111, 112]) Increase in tumor inhibition and apoptotic rate (dose-related or time-dependent) [98\u2013103], similar effect at lower dose of 5-FU [105] Induce cell cycle arrest at different phases [99, 101], increase caspase 3 and 8 expression and activity [100]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["28-year-old", "38-year-old", "47-year-old", "5-FU", "20-year-old", "40-year-old", "8-year-old", "10-year-old", "14-year-old", "16-year-old", "44-year-old", "6-year-old", "49-year-old", "30-year-old", "43-year-old", "13-year-old", "35-year-old", "15-year-old", "25-year-old", "18-year-old", "34-year-old", "32-year-old", "45-year-old", "12-year-old", "46-year-old", "37-year-old", "33-year-old", "17-year-old", "31-year-old", "9-year-old", "22-year-old", "19-year-old", "36-year-old", "39-year-old", "48-year-old", "24-year-old", "26-year-old", "41-year-old", "21-year-old", "27-year-old", "42-year-old", "7-year-old", "23-year-old", "11-year-old", "29-year-old"], "gold": [], "text": "Some Yunzhi\u2013drug combinations (5-FU, carboplatin, cisplatin, cyclophosphamide, doxorubicin, etoposide and UFT) also reduced tumor recurrence [25, 38, 42, 44] and metastasis [49]."}, {"generated": ["recent study"], "gold": [], "text": "Notably, a recent study found that such synergistic effect may be due to the inhibition of tumor metabolism via down-regulating Warburg-related proteins and restoration of the gut dysbiosis induced by paclitaxel [97]."}, {"generated": ["Yunzhi"], "gold": [], "text": "Yunzhi could also enhance the cytotoxicity of anticancer drugs via other mechanisms, such as direct increase in the activity of cytotoxic and tumor-infiltrating lymphocytes, decrease in the activity of suppressor T cells [38, 70], and decrease and increase in superoxide dismutase (SOD) and lipid peroxide levels, respectively, in cancer cells [131]."}, {"generated": ["18 years"], "gold": [], "text": "a."}, {"generated": ["Multiple mechanisms"], "gold": [], "text": "Multiple mechanisms may be involved, including upregulation of transcription factors such as T-box protein expressed in T cells (T-bet) and GATA-3, which modulate the T helper cell balance [169]; downregulation of Bax expression to reduce caspase 3 activity and T cell apoptosis [170]; and reduction of the expression of negative regulators/transcription factors of immune responses, including Forkhead box protein 3 (Foxp3) and programmed death 1 (PD-1) [171]."}, {"generated": ["women"], "gold": [], "text": "Women diagnosed with breast cancer frequently seek complementary and alternative (CAM) treatment options that can help to cope with their disease and the side effects of conventional cancer therapy."}, {"generated": ["approximately 70\u201380%"], "gold": [], "text": "Approximately 70\u201380% of all breast tumors are estrogen receptor (ER) positive [2], and hormonal therapy plays therefore an important role in the therapy of early stage and metastatic ER-positive breast cancer."}, {"generated": ["breast cancer patients"], "gold": [], "text": "Clinical studies have reported on the benefits of Viscum album extracts (VAE) not only in breast cancer patients but also for other types of cancer [10\u201313]."}, {"generated": ["dextrorphan-d", "4-hydroxy-N-desmethyltamoxifen hydrochloride", "\u03b2-estradiol"], "gold": [], "text": "(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), \u03b2-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA)."}, {"generated": ["dextrorphan-d", "4-hydroxy-N-desmethyltamoxifen hydrochloride", "\u03b2-estradiol"], "gold": [], "text": "(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), \u03b2-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA)."}, {"generated": ["dextrorphan-d", "4-hydroxy-N-desmethyltamoxifen hydrochloride", "\u03b2-estradiol"], "gold": [], "text": "(E/Z)-endoxifen hydrochloride (4-hydroxy-N-desmethyltamoxifen hydrochloride), \u03b2-estradiol (E2) and dextrorphan-d Pooled human liver microsomes (HLMs, 50 donors, mixed gender) were purchased from Bioreclamation IVT (Baltimore, USA)."}, {"generated": ["age \u2265 18 years"], "gold": [], "text": "Significances are given relative to the VAEM untreated values (*p\u00a0<\u20090.05, **p\u00a0<\u20090.01, ***p\u00a0<\u20090.001) VAEM, as well as endoxifen, showed a concentration-dependent inhibition of proliferation (Fig."}, {"generated": ["long-term outcomes"], "gold": [], "text": "The metabolic activity of CYP2D6 was suggested to be associated with the long-term outcomes in breast cancer, although the studies are inconsistent [35]."}, {"generated": ["two weeks"], "gold": [], "text": "daily for two weeks at morning and a single captopril dose (4.5\u2009mg/200\u2009g BW; p.o.)"}, {"generated": ["within-run accuracy and precision"], "gold": [], "text": "The within-run accuracy and precision of captopril analysis ranged from 1.56% to 14.38% (Table 3)."}, {"generated": ["six rats"], "gold": [], "text": "In selectivity testing, six rats plasma was used."}, {"generated": ["two weeks"], "gold": [], "text": "Two weeks of coadministration of H. sabdariffa extract is sufficient enough to affect the GSH level or the expression of the PEPT1 transporter."}, {"generated": ["2016"], "gold": [], "text": "2016)."}, {"generated": ["6"], "gold": [], "text": "(n\u00a0=\u00a06)."}, {"generated": ["Eugenia jambolana"], "gold": [], "text": "Eugenia jambolana (EJ) is an Indian traditional herb widely used for the treatment of diabetes mellitus."}, {"generated": ["several research groups studying the protective and therapeutic effect of EJE"], "gold": [], "text": "(EJ) are considered to be functional foods owing to their anti-diabetic Several research groups studying the protective and therapeutic effect of EJE and have identified presence of various classes of bioactive constituents like anthocyanins, flavonoids Gliptins are a class of oral anti-diabetic agents which act by competitively antagonizing the enzyme dipeptidyl peptidase-4 (DDP-4)."}, {"generated": ["seven days"], "gold": [], "text": "After seven days, the extract was filtered and the filtrate was stored in refrigerator until next processing."}, {"generated": ["43", "67"], "gold": [], "text": "3a and b)."}, {"generated": ["43", "67"], "gold": [], "text": "3a and b)."}, {"generated": ["diabetes"], "gold": [], "text": "The underlying mechanism of diabetes that contributes to liver damage is the combination of increased oxidative stress and an aberrant inflammatory response."}, {"generated": ["six rats"], "gold": [], "text": "Values expressed as mean\u00a0\u00b1\u00a0SEM of six rats."}, {"generated": ["18"], "gold": [], "text": "Treatment with EJE and EJE\u202f+\u202fSITA significantly (p\u202f<\u202f0.001) reduced the elevated levels of BUN (Fig."}, {"generated": ["9"], "gold": [], "text": "9, Table\u00a02)."}, {"generated": ["six rats"], "gold": [], "text": "And other experiments were divided into 2 groups: model group and M-AOE group, with six rats in each group."}, {"generated": ["0\u20137 hours"], "gold": [], "text": "The bile was collected during 0\u20131\u00a0h, 1\u20132\u00a0h, 2\u20133\u00a0h, 3\u20134\u00a0h, 4\u20135\u00a0h, 5\u20136\u00a0h and 6\u20137\u00a0h after dosing."}, {"generated": ["18-28 h", "6-18 h", "0-6 h"], "gold": [], "text": "Urine and feces were collected 0\u20136\u00a0h, 6\u201318\u00a0h and 18\u201328\u00a0h after administration."}, {"generated": ["18-28 h", "6-18 h", "0-6 h"], "gold": [], "text": "Urine and feces were collected 0\u20136\u00a0h, 6\u201318\u00a0h and 18\u201328\u00a0h after administration."}, {"generated": ["18-28 h", "6-18 h", "0-6 h"], "gold": [], "text": "Urine and feces were collected 0\u20136\u00a0h, 6\u201318\u00a0h and 18\u201328\u00a0h after administration."}, {"generated": ["China"], "gold": [], "text": "In China, Gouqizi is a popular component of the daily diet, making the prohibition of its consumption in patients taking warfarin difficult to implement."}, {"generated": ["3 days"], "gold": [], "text": "However, a daily Gouqizi dose of 6 g (dosing recommended by Chinese Pharmacopoeia) for 3 days did not enhance the effects of warfarin in three patients with prosthetic heart values who were concomitantly taking warfarin."}, {"generated": ["consistently", "dose dependent manner"], "gold": [], "text": "Animal studies have consistently shown that consumption of HS extract reduces blood pressure in a dose dependent manner."}, {"generated": ["consistently", "dose dependent manner"], "gold": [], "text": "Animal studies have consistently shown that consumption of HS extract reduces blood pressure in a dose dependent manner."}, {"generated": ["antioxidant", "antihypertensive", "hypocholesterolemic effects"], "gold": [], "text": "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, are generally believed to be the active constituents responsible for the antihypertensive, antioxidant, and hypocholesterolemic effects of HS, possibly because they are found in high relative quantities in aqueous extracts [8, 11, 13, 16]."}, {"generated": ["antioxidant", "antihypertensive", "hypocholesterolemic effects"], "gold": [], "text": "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, are generally believed to be the active constituents responsible for the antihypertensive, antioxidant, and hypocholesterolemic effects of HS, possibly because they are found in high relative quantities in aqueous extracts [8, 11, 13, 16]."}, {"generated": ["antioxidant", "antihypertensive", "hypocholesterolemic effects"], "gold": [], "text": "Anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, are generally believed to be the active constituents responsible for the antihypertensive, antioxidant, and hypocholesterolemic effects of HS, possibly because they are found in high relative quantities in aqueous extracts [8, 11, 13, 16]."}, {"generated": ["7.2"], "gold": [], "text": "7.2."}, {"generated": ["age"], "gold": [], "text": "Table 5  Cholesterol RCT interventions and effects of cholesterol RCT interventions on total cholesterol, HDL-C, LDL-C, and triglycerides."}, {"generated": ["15-day"], "gold": [], "text": "One brief 15 day study reported a significant increase in total cholesterol among hypertensive patients administered HS [18]."}, {"generated": ["extremely high doses", "lower doses"], "gold": [], "text": "Studies demonstrate that HS consumption does not adversely effect liver and kidney function at lower doses, but may be hepatotoxic at extremely high doses."}, {"generated": ["extremely high doses", "lower doses"], "gold": [], "text": "Studies demonstrate that HS consumption does not adversely effect liver and kidney function at lower doses, but may be hepatotoxic at extremely high doses."}, {"generated": ["clinically relevant"], "gold": [], "text": "Conversely, S. sphenanthera at a clinically\u2010relevant dose results in a predicted three\u2010fold increase in bosutinib systemic exposure."}, {"generated": ["age \u2265 18 years"], "gold": [], "text": "Go to: 2."}, {"generated": ["2.1.2"], "gold": [], "text": "2.1.2."}, {"generated": ["Theoretically, the discrimination between competitive and noncompetitive inhibitions"], "gold": [], "text": "Theoretically, the discrimination between competitive and noncompetitive inhibitions is not critical when concentrations of substrates are much lower than their K m values, which is often the case in the clinical setting."}, {"generated": ["4"], "gold": [], "text": "MBI, mechanism\u2010based inhibition Go to: 4."}, {"generated": ["72"], "gold": [], "text": "by carbamazepine and phenytoin, 72 the predominant outcome from a chronic exposure to Schisandra lignans is a CYP3A inhibition and not induction."}, {"generated": ["Sixty"], "gold": [], "text": "Sixty Sprague\u2013Dawley rats were used to investigate the effects of warfarin (0.2\u00a0mg/kg), Danshen (240 or 480\u00a0mg/kg) and Gegen (240 or 480\u00a0mg/kg) both in isolation and combination."}, {"generated": ["total running time of 90 minutes"], "gold": [], "text": "The linear gradient elution was carried out as follows with a total running time of 90\u00a0min: solvent A was kept at 5\u00a0% for the first 5\u00a0min, and then increased to 10, 17, 35 and 90\u00a0% in the next 13, 12, 10 and 30\u00a0min, respectively, then returned to 5\u00a0% in 5\u00a0min and equilibrated for 15\u00a0min before the next injection."}, {"generated": ["24, 32"], "gold": [], "text": "Danshen and Gegen elicit their effects by improving microcirculation and inhibiting platelet aggregation [24, 32], whereas warfarin exerts its anticoagulant effect by inhibiting the activity of VKOR and inducing TM."}, {"generated": ["no clinical reports"], "gold": [], "text": "Although there were no clinical reports in the literature pertaining to the interactions between Gegen and warfarin, the results of several case reports indicated that Danshen can interact with warfarin in humans [20\u201322]."}, {"generated": ["rats", "human"], "gold": [], "text": "Although these isoforms are expressed in several different species, a high degree of similarity in their gene sequences between rats and human may not automatically result in similar levels of catalytic specificity and activity."}, {"generated": ["rats", "human"], "gold": [], "text": "Although these isoforms are expressed in several different species, a high degree of similarity in their gene sequences between rats and human may not automatically result in similar levels of catalytic specificity and activity."}, {"generated": ["BKG, ZZh", "Danshen\u2013Gegen Formula", "ZZu"], "gold": [], "text": "liver cytochrome P450 vitamin K epoxide reductase vitamin K vitamin K thrombomodulin Danshen\u2013Gegen Formula salvianolic acid B phenobarbital beta-naphthoflavone cyclophosphamide enzyme-linked immunosorbent assay Beikang Ge and Zhen Zhang contributed equally to this work BKG, ZZh and ZZu conceived and designed the study."}, {"generated": ["BKG, ZZh", "Danshen\u2013Gegen Formula", "ZZu"], "gold": [], "text": "liver cytochrome P450 vitamin K epoxide reductase vitamin K vitamin K thrombomodulin Danshen\u2013Gegen Formula salvianolic acid B phenobarbital beta-naphthoflavone cyclophosphamide enzyme-linked immunosorbent assay Beikang Ge and Zhen Zhang contributed equally to this work BKG, ZZh and ZZu conceived and designed the study."}, {"generated": ["BKG, ZZh", "Danshen\u2013Gegen Formula", "ZZu"], "gold": [], "text": "liver cytochrome P450 vitamin K epoxide reductase vitamin K vitamin K thrombomodulin Danshen\u2013Gegen Formula salvianolic acid B phenobarbital beta-naphthoflavone cyclophosphamide enzyme-linked immunosorbent assay Beikang Ge and Zhen Zhang contributed equally to this work BKG, ZZh and ZZu conceived and designed the study."}, {"generated": ["no difference in the toxicity profile"], "gold": [], "text": "There was no difference in the toxicity profile of hormone therapy with ginkgo biloba use in women with early stage breast cancer."}, {"generated": ["37"], "gold": [], "text": "The 48 (80%) women who had received adjuvant chemotherapy were a mean of 37\u2009months (range 4\u2013113) from completion of chemotherapy."}, {"generated": ["chronically ill patients", "patients with terminal diseases"], "gold": [], "text": "Increasing use of medicinal herbs as nutritional supplements and traditional medicines for the treatment of diabetes, hypertension, hyperlipidemia, and malaria fever with conventional drugs poses possibilities of herb\u2013drug interactions ( In vitro inhibition of eight major   Mangifera indica moderately inhibited  Potential for clinically important     Funding information  This research did not receive any specific grant from funding agencies in the public, commercial, or not\u2010for\u2010profit sectors Management of chronic diseases is burdensome to patients (Eton et\u00a0al., 2013; \u00d8rtenblad, Meillier, & J\u00f8nsson, 2017) who tend to seek alternative remedies to conventional medications that may supposedly provide cure or offer safe use (Yarney et\u00a0al., 2013; Joeliantina, Agil, Qomaruddin, Jonosewojo, & Kusnanto, 2016) This self\u2010medication practice is common among chronically ill patients or patients with terminal diseases (Bodenheimer, Lorig, Holman, & Grumbach, 2002; Hasan, Ahmed, Bukhari, & Loon, 2009), and the major culprit in this group of patients are dietary supplements and herbal medicines (Gardiner, Graham, Legedza, Eisenberg, & Phillips, 2006; Gardiner, Phillips, & Shaughnessy, 2008)."}, {"generated": ["chronically ill patients", "patients with terminal diseases"], "gold": [], "text": "Increasing use of medicinal herbs as nutritional supplements and traditional medicines for the treatment of diabetes, hypertension, hyperlipidemia, and malaria fever with conventional drugs poses possibilities of herb\u2013drug interactions ( In vitro inhibition of eight major   Mangifera indica moderately inhibited  Potential for clinically important     Funding information  This research did not receive any specific grant from funding agencies in the public, commercial, or not\u2010for\u2010profit sectors Management of chronic diseases is burdensome to patients (Eton et\u00a0al., 2013; \u00d8rtenblad, Meillier, & J\u00f8nsson, 2017) who tend to seek alternative remedies to conventional medications that may supposedly provide cure or offer safe use (Yarney et\u00a0al., 2013; Joeliantina, Agil, Qomaruddin, Jonosewojo, & Kusnanto, 2016) This self\u2010medication practice is common among chronically ill patients or patients with terminal diseases (Bodenheimer, Lorig, Holman, & Grumbach, 2002; Hasan, Ahmed, Bukhari, & Loon, 2009), and the major culprit in this group of patients are dietary supplements and herbal medicines (Gardiner, Graham, Legedza, Eisenberg, & Phillips, 2006; Gardiner, Phillips, & Shaughnessy, 2008)."}, {"generated": ["chronic diseases"], "gold": [], "text": "Others such as Alstonia boonei, Bauhinia monandra, and Picralima nitida are frequently used in sub\u2010Saharan Africa and India in the management of chronic diseases such as hypertension, diabetes, asthma, peptic ulcer, and cancer, as antimalarials and antimicrobials and other minor ailments (Mahomoodally, 2013; Ezuruike & Prieto, 2014; Iwu, 2014)."}, {"generated": ["unknown"], "gold": [], "text": "Little is known of the effect of most tropical medicinal herbs on the metabolic capacity of CYP isoenzymes."}, {"generated": ["50%"], "gold": [], "text": "Fifty percent inhibitory concentration (IC   where A\u00a0=\u00a0log of concentration of aqueous extract of herb in the incubations."}, {"generated": ["aqueous extract"], "gold": [], "text": "In this study, aqueous extract of oven\u2010dried Allium sativum bulbs was used."}, {"generated": ["2000"], "gold": [], "text": "(2000)."}, {"generated": ["in vivo"], "gold": [], "text": "Gongronema latifolium and Alstonia boonei may produce in vivo inhibitory activity on CYP1A2, CYP2C19 and CYP3A4 since the converted in vitro IC One of the problems of studying herb\u2013drug interactions is the difficulty in identifying or quantifying the inhibiting components of the complex mixtures of phytochemicals in the herb."}, {"generated": ["2020"], "gold": [], "text": "2020; 81:XXX\u2013XXX) Transition to menopause is associated with a period of increased risk for problematic symptoms, including hot flashes, night sweats, sleep disturbances, sexual dysfunction, mood disorders, weight gain, and cognitive declines."}, {"generated": ["2.5L"], "gold": [], "text": "34860-2.5L-R) and ammonium acetate (catalog No."}, {"generated": ["age \u2265 18 years"], "gold": [], "text": "The following formula determines the half-maximal inhibitory concentration (IC SRM Medical College Hospital and Research Centre and SRM Institute of Science and Technology, Kattankulathur ethics committees approved the protocol (approval No."}, {"generated": ["female volunteers"], "gold": [], "text": "Female volunteers were excluded if they were pregnant (positive test for serum human chorionic gonadotropin at screening or check-in), breastfeeding, or planning to conceive a child within 30 days of treatment cessation."}, {"generated": ["mean"], "gold": [], "text": "The mean (SD) plasma concentrations of simvastatin, its metabolite simvastatin hydroxy acid, and internal standard lovastatin are shown in Figure\u00a04."}, {"generated": ["40"], "gold": [], "text": "(B) Plasma obtained from the volunteer received single oral dose of 40 mg simvastatin."}, {"generated": ["2 weeks"], "gold": [], "text": "Table 3  Platelet aggregation (Ohms) after 2 weeks of echinacea and policosanol pre-treatment (n= 12) \tControl\tPolicosanol treatment\tEchinacea treatment Agonist\tMean (95% CI)\tMean (95% CI)\tGeometric mean ratio to control (90% CI)\tMean (95% CI)\tGeometric mean ratio to control (90% CI) ADP*\t7.8 (5.5, 10.0)\t6.8 (4.9, 8.8)\t0.92 (0.64, 1.30)\t7.5 (4.1, 10.8)\t0.84 (0.59, 1.19) Arachidonic acid\t11.0 (9.6, 12.5)\t11.2 (9.4, 12.9)\t1.00 (0.82, 1.23)\t12.1 (9.3, 15.0)\t1.06 (0.86, 1.30) Collagen\t13.0 (11.5, 14.6)\t14.9 (12.6, 17.2)\t1.13 (0.93, 1.37)\t15.8 (12.2, 19.5)\t1.17 (0.97, 1.42) Open in a separate window *Adenosine diphosphate."}, {"generated": ["Jamaican prescription drug users", "cancer patients"], "gold": [], "text": "A survey of cancer patients attending the oncology and urology clinics at the University Hospital of the West Indies in Kingston, and two earlier surveys of Jamaican prescription drug users identified high levels of herb-drug use (80% [4] 80% [5] and 81% [6], respectively), while awareness of such herb-drug use amongst health care professionals was low across all four surveys (13% [5], 15% [4], 18% [6] and 19% [3], respectively)."}, {"generated": ["Jamaican prescription drug users", "cancer patients"], "gold": [], "text": "A survey of cancer patients attending the oncology and urology clinics at the University Hospital of the West Indies in Kingston, and two earlier surveys of Jamaican prescription drug users identified high levels of herb-drug use (80% [4] 80% [5] and 81% [6], respectively), while awareness of such herb-drug use amongst health care professionals was low across all four surveys (13% [5], 15% [4], 18% [6] and 19% [3], respectively)."}, {"generated": ["In vitro"], "gold": [], "text": "The IC It was not possible to determine the IC In vitro CYP assays offer an accurate, and relatively inexpensive, first stage assessment tool for gauging the potential for herb-drug interactions."}, {"generated": ["15"], "gold": [], "text": "[15] to screen natural products for cytochrome P450 inhibition potential with a particular emphasis on the P450 enzymes, CYPs 1A1, 1A2, 1B1, 3A4 and 2D6."}, {"generated": ["35"], "gold": [], "text": "[35]."}, {"generated": ["100 \u00b5L"], "gold": [], "text": "100 \u00b5L of various concentrations of the extracts, and the ascorbic acid control, in methanol, were added to 100 \u00b5L of a 0.02% (w/v) stock solution of the free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) in methanol."}, {"generated": ["five days"], "gold": [], "text": "Five days after presentation, her symptoms had completely resolved."}, {"generated": ["8 mg/mL"], "gold": [], "text": "The reaction was terminated by adding 5\u202f\u03bcL of 8\u202fmg/mL dichlorvos and then mixed with 600\u202f\u03bcL PBS."}, {"generated": ["30 minutes"], "gold": [], "text": "At 30\u202fmin following the 8PM dose on Day 5, the rats were anesthetized and about 10\u202fmL of blood were collected from rats\u2019 inferior vena for determination of antiviral activity."}, {"generated": ["rat plasma"], "gold": [], "text": "The incubation system for rat plasma contains 1\u202f\u03bcg/mL of OS and 10% rat plasma since the super-fast reaction rate of 100% rat plasma resulted in no discrimination for nearly all the studied herb/herbal components."}, {"generated": ["significantly suppressed"], "gold": [], "text": "The formation rate of OSA could be significantly suppressed by all the herb/herbal components."}, {"generated": ["rat urine samples"], "gold": [], "text": "This can further be verified by the lowered OSA/OS ratio in rat urine samples after co-administration with RS (Fig."}, {"generated": ["67"], "gold": [], "text": "S8)."}, {"generated": ["rat plasma"], "gold": [], "text": "The metabolic inhibition studies performed in rat plasma suggested that all the herbal extracts (500\u202f\u03bcg/mL) and all the herbal components (100\u202f\u03bcg/mL) could inhibit the hydrolysis of OS in rat plasma, but the % inhibition rate varied between herbs/herbal components."}, {"generated": ["rat plasma"], "gold": [], "text": "The hydrolase activities in rat plasma may be originated from more than one kind of enzymes (not only hCE1) and the inhibition activities of these herbal components to each kind of hydrolysis enzymes are different."}, {"generated": ["after co-administration with RS"], "gold": [], "text": "As shown in Table 1, after co-administration with RS, BIO of OS increased by 62% without change in its absorption rate (k  The developed pop-PK model lets us have an interpretation on the contradictory phenomena that co-administration of RS would increase both the elimination rate and systemic exposure (AUC The pop-PK model could separately estimate the metabolic clearance (CL  A platform including a six-dimension in-vitro screening, an in-vivo pharmacokinetics in rats and an ex-vivo pharmacodynamic evaluation, has been developed and successfully applied to find RS as a potential herb that would influence the co-administrated OS in rats."}, {"generated": ["30%-70%"], "gold": [], "text": "30%\u201370% of clinical breast cancer patients use natural products, which may increase the likelihood of drug interactions."}, {"generated": ["breast cancer patients"], "gold": [], "text": "Of all the cancer patients, breast cancer patients, in particular, are more likely to turn to complementary and alternative medicine (CAM) treatment (Wanchai et al., 2010)."}, {"generated": ["2009", "2011", "2013"], "gold": [], "text": "The key mechanisms of action of anti-cancer drugs involve apoptosis, autophagy, and cell cycle arrest (Chen and Karantza-Wadsworth, 2009; Wang et el., 2011; Kon et al., 2013)."}, {"generated": ["2009", "2011", "2013"], "gold": [], "text": "The key mechanisms of action of anti-cancer drugs involve apoptosis, autophagy, and cell cycle arrest (Chen and Karantza-Wadsworth, 2009; Wang et el., 2011; Kon et al., 2013)."}, {"generated": ["2009", "2011", "2013"], "gold": [], "text": "The key mechanisms of action of anti-cancer drugs involve apoptosis, autophagy, and cell cycle arrest (Chen and Karantza-Wadsworth, 2009; Wang et el., 2011; Kon et al., 2013)."}, {"generated": ["recent"], "gold": [], "text": "A recent study has shown that the combined use of HES, PIP, and BV with TAM showed an enhanced anti-proliferative effect on MCF7 and T47D and can significantly increase cell apoptosis (Khamis et al., 2018)."}, {"generated": ["Don (P. capitatum)"], "gold": [], "text": "ex D. Don (P. capitatum), a Chinese herbal plant, is often used alone or in combination with antibacterial agents to treat urinary tract infections, pyelonephritis, and prostatitis in China (Chinese Pharmacopoeia Commission, 2010; Liao et al., 2011)."}, {"generated": ["11.5\u201313.5 min", "14\u201315 min", "0\u20138.5 min", "8.7\u201311 min"], "gold": [], "text": "The gradient elution program was as follows: 0\u20138.5\u00a0min, 97% A; 8.7\u201311\u00a0min, 60% A; 11.5\u201313.5\u00a0min, 10% A; 14\u201315\u00a0min, 97% A."}, {"generated": ["11.5\u201313.5 min", "14\u201315 min", "0\u20138.5 min", "8.7\u201311 min"], "gold": [], "text": "The gradient elution program was as follows: 0\u20138.5\u00a0min, 97% A; 8.7\u201311\u00a0min, 60% A; 11.5\u201313.5\u00a0min, 10% A; 14\u201315\u00a0min, 97% A."}, {"generated": ["11.5\u201313.5 min", "14\u201315 min", "0\u20138.5 min", "8.7\u201311 min"], "gold": [], "text": "The gradient elution program was as follows: 0\u20138.5\u00a0min, 97% A; 8.7\u201311\u00a0min, 60% A; 11.5\u201313.5\u00a0min, 10% A; 14\u201315\u00a0min, 97% A."}, {"generated": ["11.5\u201313.5 min", "14\u201315 min", "0\u20138.5 min", "8.7\u201311 min"], "gold": [], "text": "The gradient elution program was as follows: 0\u20138.5\u00a0min, 97% A; 8.7\u201311\u00a0min, 60% A; 11.5\u201313.5\u00a0min, 10% A; 14\u201315\u00a0min, 97% A."}, {"generated": ["normal rats"], "gold": [], "text": "PCE significantly increased the tissue to plasma distribution coefficients (K  Tissue distribution profiles of ciprofloxacin (CIP) after intravenous administration of CIP in the absence (A) and presence (B) of PCE to rats, as well as the tissue to plasma distribution coefficients [K  The tissue distribution curves of GA in normal rats after intragastric administration of PCE in the absence and presence of CIP are displayed in Figures 7A,B, respectively."}, {"generated": ["neither significantly affected"], "gold": [], "text": "Total Energy Expenditure (TEE) was neither significantly affected by the treatment (YM vs. PLC) nor the exercise time (Figure 3)."}, {"generated": ["24%"], "gold": [], "text": "This increase is comparable with 24% increase found during low to moderate exercise intensities determined using an incremental protocol in our previous study [22]."}, {"generated": ["human participants"], "gold": [], "text": "Previous studies in human participants have shown promising effects of YM ingestion on metabolic rate and RER acutely [21], and after 12 weeks of ingestion, on blood lipid metabolites in healthy obese participants [11,21]."}, {"generated": ["all females"], "gold": [], "text": "The BF% data indicated all females who took part were at the lower BF% percentile, indicating that they were physically active, with higher  Although the positive effects of YM on fat-loss outcomes during exercise are found only in single trials, future research could test the longitudinal YM effectiveness, especially when combining regular exercise training with YM treatment."}, {"generated": ["clinically significant improvement"], "gold": [], "text": "Several controlled clinical studies, as shown by review and meta-analysis of published data, suggest that the use of ginkgo is associated with clinically significant improvement in symptoms of cognition decline and memory loss, anxiety and mood disorders, fatigue and general well-being, as well as cardiovascular disorders [59-61]."}, {"generated": ["general"], "gold": [], "text": "Despite the general concern about its safety, kava is still popularly consumed for CNS benefits."}, {"generated": ["18-year-old"], "gold": [], "text": "A study in 18 health volunteers did not show any clinically relevant interaction between kava and bromazepam [104]."}, {"generated": ["21-year-old"], "gold": [], "text": "investigated the ability of SJW to interact with CYP3A4 in a 2-way, open-label crossover study of 21 healthy subjects using midazolam as the probe substrate."}, {"generated": ["Medicinal herbs"], "gold": [], "text": "Medicinal herbs are rich sources of natural bioactive compounds that could interact with drugs."}, {"generated": ["mean"], "gold": [], "text": "Data are expressed as mean \u00b1 S. D. (n = 6)."}, {"generated": ["et Zucc."], "gold": [], "text": "et Zucc.)"}, {"generated": ["pretreatment period"], "gold": [], "text": "Second, the pretreatment period of Epimedium sagittatum extract might have been too short to identify the possible herbal drug effect."}, {"generated": ["often over years"], "gold": [], "text": "Though non-pharmacological treatments are the main therapy for these patients, application of analgetic drugs is common, often over years."}, {"generated": ["56.6%"], "gold": [], "text": "They found a prevalence of 56.6%."}, {"generated": ["Spanish"], "gold": [], "text": "A Spanish study reports Aloe vera [37]."}, {"generated": ["5 ppm"], "gold": [], "text": "For the refined quantified dry extract, the ginkgolic acid content is limited to 5 ppm [154]."}, {"generated": ["thrombin"], "gold": [], "text": "There are in vitro experiments confirming thrombin inhibition [172]."}, {"generated": ["3 weeks"], "gold": [], "text": "applied atorvastatin in rats after 3 weeks of drinking green tea or water."}, {"generated": ["CYP2C9", "CYP3A4"], "gold": [], "text": "Curcuminoids have been shown to inhibit CY3A4 and 2C9 in vitro [230]."}, {"generated": ["CYP2C9", "CYP3A4"], "gold": [], "text": "Curcuminoids have been shown to inhibit CY3A4 and 2C9 in vitro [230]."}, {"generated": ["human"], "gold": [], "text": "Willow bark extract showed a smaller effect on platelet aggregation in humans than ASA [234]."}, {"generated": ["sulfur compounds"], "gold": [], "text": "It is composed of a large number of sulfur compounds, with suspected bioactive compounds called allyl thiosulfinates (mainly allicin) [65]."}, {"generated": ["two millennia"], "gold": [], "text": "This herb has been in use for diabetic treatment for almost two millennia [72]."}, {"generated": ["in vitro study"], "gold": [], "text": "In the in vitro study, Asafetida resin alcoholic extract inhibited the formation of DOR from DEX in a concentration dependent manner (Fig."}, {"generated": ["25"], "gold": [], "text": "The activation was highest at 25\u00a0\u03bcg/ml concentration."}, {"generated": ["healthy human volunteers"], "gold": [], "text": "The in vivo study was conducted on healthy human volunteers."}], "FN": [{"generated": ["greater than 65 years"], "gold": ["greater than 65 years of age"], "text": "[1\u20133,8,9] Still other surveys indicate that herbal supplement usage is prevalent among patients taking prescription medications,[10\u201312] with many individuals greater than 65 years of age."}, {"generated": ["20-60 years"], "gold": ["20\u201360 years"], "text": "Regarding CAM nonusers, the majority were in the age group of 20\u201360 years with the male/female ratio of 73/27 percent."}, {"generated": ["50-70 years"], "gold": ["50\u201370 years"], "text": "The majority of the patients identified as herbal users were in the age range of 50\u201370 years, and herbal usage prevalence was high among this age range."}, {"generated": ["50-64"], "gold": ["50\u201364"], "text": "'s study,[25] which reported that the trend was more prevalent among middle-aged (50\u201364) patients compared to other age groups."}]}